• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABIOMED, INC. - 1220648 IMPELLA; TEMPORARY NON-ROLLER TYPE LEFT HEART SUPPORT BLOOD PUMP

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABIOMED, INC. - 1220648 IMPELLA; TEMPORARY NON-ROLLER TYPE LEFT HEART SUPPORT BLOOD PUMP Back to Search Results
Catalog Number 0048-0045
Medical Device Problem Code Patient Device Interaction Problem (4001)
Health Effect - Clinical Codes Hemorrhage/Blood Loss/Bleeding (1888); Ischemia (1942); Thromboembolism (2654)
Date of Event 12/09/2021
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by abiomed inc, or its employees that the report constitutes an admission that the product, abiomed inc, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.
 
Event or Problem Description
Clincial narrative: an impella cp was inserted via the femoral artery to support an 82 year old male patient who had been admitted in with known coronary artery disease and plan for a protected percutaneous coronary intervention (pci).The patient's underlying medical history was not shared.The cp was inserted but, the team did not use ultrasound guidance to access with micropuncture technique.The site developed a hematoma.This bleed required intervention to treat.They found the need to apply manual pressure and then close the site with two stents after occlusive thrombus was observed at the femoral site.The femoral site was not the only bleed location.The team used manual pressure and tegaderm to also resolve the radial lines bleeding.These measures resolved the small hematomas.The patient survived both the pci and interventions for the bleeding.Of note, anticoagulation necessary for the pump placement and support can contribute to access site bleeding.
 
Additional Manufacturer Narrative
H6: updated codes based on the results of the investigation.H11: updated based on the results of the investigation and added clinical review.Upon review, it was identified that the information was inadvertently not submitted in the initial report.The root cause of the injury was unable to be determined due to insufficient clinical details.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
IMPELLA
Common Device Name
TEMPORARY NON-ROLLER TYPE LEFT HEART SUPPORT BLOOD PUMP
Manufacturer (Section D)
ABIOMED, INC. - 1220648
22 cherry hill drive
danvers MA 01923
Manufacturer Contact
derek sammarco
22 cherry hill drive
danvers, MA 01923
7814934967
MDR Report Key25126092
Report Number1220648-2026-07694
Device Sequence Number18308082
Product Code OZD
UDI-Device Identifier00813502011876
UDI-Public(01)00813502011876(17)230930(10)2022143974
Combination Product (Y/N)N
Initial Reporter StateLA
Initial Reporter CountryUS
PMA/510(K) Number
P140003
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2021
Device Explanted Year2021
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Study,Health Professional,User Facility,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date09/30/2023
Device Catalogue Number0048-0045
Device Lot Number2022143974
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 04/09/2026
Supplement Date Received by Manufacturer05/20/2026
Initial Report FDA Received Date05/08/2026
Supplement Report FDA Received Date05/21/2026
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured11/23/2021
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age82 YR
Patient SexMale
Patient EthnicityNon Hispanic
Patient RaceWhite
-
-